Tuberculosis after anti-TNF therapy: a continuous learning process

被引：2

作者：

Psichogiou, M. ^{[1
]}

Sfikakis, P. P. ^{[1
]}

Kontos, F. ^{[2
]}

Daikos, G. L. ^{[1
]}

机构：

[1] Univ Athens, Dept Propaedeut Med 1, Athens, Greece

[2] Attikon Univ Hosp, Clin Microbiol Lab, Athens, Greece

来源：

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2012年 / 41卷 / 05期

关键词：

ANTITUMOR NECROSIS FACTOR; IMMUNE RECONSTITUTION; PARADOXICAL RESPONSE; PATIENT;

D O I：

10.3109/03009742.2012.676063

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：401 / 403

页数：3

共 9 条

[1] A patient with de novo tuberculosis during anti-tumor necrosis factor-α therapy illustrating diagnostic pitfalls and paradoxical response to treatment [J].

Arend, Sandra M. ;

Leyten, Eliane M. S. ;

Franken, Willeke P. J. ;

Huisman, Erik M. ;

van Dissel, Jaap T. .

CLINICAL INFECTIOUS DISEASES, 2007, 45 (11) :1470-1475

[2]

Belknap R, 2005, INT J TUBERC LUNG D, V9, P1057

[3] Immune reconstitution and "Unmasking" of tuberculosis during antiretroviral therapy [J].

Lawn, Stephen D. ;

Wilkinson, Robert J. ;

Lipman, Marc C. I. ;

Wood, Robin .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (07) :680-685

[4] BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment [J].

Ormerod, LP ;

Milburn, HJ ;

Gillespie, S ;

Ledingham, J ;

Rampton, D .

THORAX, 2005, 60 (10) :800-805

[5] American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis [J].

Saag, Kenneth G. ;

Teng, Gim Gee ;

Patkar, Nivedita M. ;

Anuntiyo, Jeremy ;

Finney, Catherine ;

Curtis, Jeffrey R. ;

Paulus, Harold E. ;

Mudano, Amy ;

Pisu, Maria ;

Elkins-Melton, Mary ;

Outman, Ryan ;

Allison, Jeroan J. ;

Almazor, Maria Suarez ;

Bridges, S. Louis, Jr. ;

Chatham, W. Winn ;

Hochberg, Marc ;

Maclean, Catherine ;

Mikuls, Ted ;

Moreland, Larry W. ;

O'Dell, James ;

Turkiewicz, Anthony M. ;

Furst, Daniel E. .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (06) :762-784

[6]

Vidal CG, 2005, CLIN INFECT DIS, V40, P756, DOI 10.1086/427941

[7] Delayed response to anti-tuberculosis treatment in a patient on infliximab [J].

Vlachaki, E ;

Psathakis, K ;

Tsintiris, K ;

Iliopoulos, A .

RESPIRATORY MEDICINE, 2005, 99 (05) :648-652

[8] Adalimumab Treatment of Life-Threatening Tuberculosis [J].

Wallis, Robert S. ;

van Vuuren, Cloete ;

Potgieter, Samantha .

CLINICAL INFECTIOUS DISEASES, 2009, 48 (10) :1429-1432

[9] Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: Case finding through the emerging infections network [J].

Winthrop, Kevin L. ;

Yamashita, S. ;

Beekmann, S. E. ;

Polgreen, P. M. .

CLINICAL INFECTIOUS DISEASES, 2008, 46 (11) :1738-1740

← 1 →